Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 3055-3061

  Minniti, G ^a,b   Salvati, M ^b   Muni, R ^a   Lanzetta, G ^b   Osti, M F ^a   Clarke, E ^a   Costa, A ^c   Bozzao, A ^a   Trasimeni, G ^a   Maurizi Enrici, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c Italian Neurological Institute (INI)   (Italy)

Author keywords

Multiple brain metastases; Non small cell lung cancer; Radiotherapy; Stereotactic radiosurgery; Survival; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; AMNESIA; ARTICLE; BRAIN METASTASIS; BRAIN RADIOGRAPHY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONFUSION; CONTROLLED STUDY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RISK REDUCTION; STEREOTACTIC RADIOSURGERY; TREATMENT DURATION;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOSURGERY; RADIOTHERAPY; SURVIVAL RATE;

EID: 77955787619     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ryan GF, Ball DL and Smith JG: Treatment of brain metastases from primary lung cancer. Int J Radiat Oncol Biol Phys 31: 273-278, 1995.
2. Sen M, Demiral AS, Cetingöz R, Alanyali H, Akman F, Sentürk D and Kinay M: Prognostic factors in lung cancer with brain metastasis. Radiother Oncol 46: 33-38, 1998. (Pubitemid 28072856)
3. Rodrigus P, de Brouwer P and Raaymakers E: Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation. Lung Cancer 32: 129-136, 2001.
4. Borgelt B, Gelber R, Kramer S, Brady LW, Chang CH, Davis LW, Perez CA and Hendrickson FR: The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6: 1-9, 1980. (Pubitemid 10103009)
5. Cairncross JG, Kim JH and Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529-541, 1980.
6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997. (Pubitemid 27181303)
7. Mehta MP, Shapiro WR, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, Roa WH, Leibenhaut M, Ford J, Curran W, Phan S, Smith JA, Miller RA and Renschier MF: Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20: 3445-3453, 2002.
8. Kepka L, Cieslak E, Bujko K, Fijuth J and Wierzchowski M: Results of whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol 44: 389-398, 2005. (Pubitemid 41021044)
9. Rades D, Schild SE, Lohynska R, Veninga T, Stalpers LJ and Dunst J: Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients. Cancer 110: 1077-1082, 2007. (Pubitemid 47312874)
10. Videtic GM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GH, Lee SY and Suh JH: Validation of the RTOG recursive partitioning analysis (RPA) classification for small cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67: 240-243, 2007.
11. Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S and Mehta MP: Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 51: 426-434, 2001.
12. Chitapanarux I, Goss B, Vongtama R, Frighetto L, De Salles A, Selch M, Duick M, Solberg T, Wallace R, Cabatan-Awang C and Ford J: Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy. J Neurooncol 61: 143-149, 2003.
13. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP and Curran WJ Jr.: Whole-brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672, 2004.
14. Kocher M, Maarouf M, Bendel M, Voges J, Müller RP and Sturm V: LINAC radiosurgery versus whole brain radiotherapy for brain metastases: A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol 180: 263-267, 2004. (Pubitemid 38667745)
15. Kondziolka D, Patel A, Lunsford LD, Kassam A and Flickinger JC: Stereotactic radiosurgery plus whole-brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45: 427-434, 1999. (Pubitemid 29408559)
16. Chidel MA, Suh JH, Reddy CA, Chao ST, Lundbeck MF and Barnett GH: Application of recursive partitioning analysis and evaluation of the use of whole-brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 47: 993-999, 2000.
17. Sheehan JP, Sun MH, Kondziolka D, Flickinger J and Lunsford LD: Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control. J Neurosurg 97: 1276-1281, 2002. (Pubitemid 35424280)
18. Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M and Debus J: Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic LINAC-based radiosurgery: prognostic factors. Lung Cancer 37: 87-94, 2002. (Pubitemid 34621463)
19. Gerosa M, Nicolato A, Foroni R, Tomazzoli L and Bricolo A: Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery. J Neurosurg 102(Suppl): 75-80, 2005. (Pubitemid 44783929)
20. Sheehan J, Kondziolka D, Flickinger J and Lunsford LD: Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 102(Suppl): 247-254, 2005. (Pubitemid 44783963)
21. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS and Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494-500, 1990. (Pubitemid 20067825)
22. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R and Wannenmacher M: Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 16: 3563-3569, 1998. (Pubitemid 28506769)
23. Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW and Mehta MP: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole-brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53: 519-526, 2002.
24. Pollock BE, Brown PD, Foote RL, Stafford SL and Schomberg PJ: Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 61: 73-80, 2003.
25. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N and Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483-2491, 2006.
26. Natale RB, Bodkin D, Govindan R, Sleckman BG, Rizvi NA, Capó A, Germonpré P, Eberhardt WE, Stockman PK, Kennedy SJ and Ranson M: Vandetanib versus gefitinib in patients with advanced non-small cell lung cancer: results from a two-part, double-blind, randomized phase II study. J Clin Oncol 27: 2523-2529, 2009.
27. Patel JD, Hensing TA, Rademaker A, Hart EM, Blum MG, Milton DT and Bonomi PD: Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer. J Clin Oncol 27: 3284-3289, 2009.
28. Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R, Vynnychenko I, Park K, Yu CT, Ganul V, Roh JK, Bajetta E, O'Byrne K, de Marinis F, Eberhardt W, Goddemeier T, Emig M and Gatzemeier U; FLEX Study Team: Cetuximab plus chemotherapy in patients with advanced non-small cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373: 1525-1531, 2009.
29. Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N and Manegold C: Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small cell lung cancer: AVAil. J Clin Oncol 27: 1227-1234, 2009.
30. Mueller RP, Soffietti R, Abacioglu MU, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Collette L and Kocher M: Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study, J Clin Oncol 27 (suppl): 15s, 2009.
31. Bindal RK, Sawaya R, Leavens ME and Lee JJ: Surgical treatment of multiple brain metastases. J Neurosurg 79: 210-216, 1993. (Pubitemid 23215837)
32. Paek SH, Audu PB, Sperling MR, Cho J and Andrews DW: Re-evaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 56: 1021-1034, 2005. (Pubitemid 40628104)
33. Stark AM, Tscheslog H, Buhl R, Held-Feindt J and Mehdorn HM: Surgical treatment for brain metastases: prognostic factors and survival in 177 patients. Neurosurg Rev 25: 115-119, 2005. (Pubitemid 40543809)
34. Rades D, Bohlen G, Pluemer A, Veninga T, Hanssens P, Dunst J and Schild SE: Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer 109: 2515-2521, 2007. (Pubitemid 46906471)
35. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ and Kreth FW: Microsurgery plus whole-brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87: 299-307, 2008.
36. Rades D, Kueter JD, Pluemer A, Veninga T and Schild SE: A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases. Int J Radiat Oncol Biol Phys 73: 1077-1081, 2009.
37. Al-Shamy G and Sawaya R: Management of brain metastases: the indispensable role of surgery. J Neurooncol 92: 275-282, 2009.